acetopyrrothine has been researched along with Angiogenesis, Pathologic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishizuka, M; Kawada, M; Kumagai, H; Masuda, T; Minamiguchi, K; Takeuchi, T | 1 |
1 other study(ies) available for acetopyrrothine and Angiogenesis, Pathologic
Article | Year |
---|---|
Thiolutin, an inhibitor of HUVEC adhesion to vitronectin, reduces paxillin in HUVECs and suppresses tumor cell-induced angiogenesis.
Topics: Animals; Antifungal Agents; Blotting, Western; Cell Adhesion; Cell Adhesion Molecules; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Down-Regulation; Endothelium, Vascular; Female; Humans; Immunoblotting; Intercellular Signaling Peptides and Proteins; Mice; Mice, Inbred ICR; Neovascularization, Pathologic; Paxillin; Peptides; Phosphoproteins; Platelet Aggregation Inhibitors; Precipitin Tests; Pyrrolidinones; Receptors, Vitronectin; Tumor Cells, Cultured; Umbilical Veins; Vitronectin | 2001 |